Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
GT Biopharma Inc (NASDAQ: GTBP) closed the day trading at $0.79 down -0.75% from the previous closing price of $0.8. In other words, the price has decreased by -$0.75 from its previous closing price. On the day, 1.1 million shares were traded. GTBP stock price reached its highest trading level at $0.8062 during the session, while it also had its lowest trading level at $0.77.
Ratios:
For a better understanding of GTBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.70 and its Current Ratio is at 2.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTBP now has a Market Capitalization of 8445092 and an Enterprise Value of 5918091.
Stock Price History:
The Beta on a monthly basis for GTBP is 1.21, which has changed by -0.6862745 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, GTBP has reached a high of $3.85, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 11.60%, while the 200-Day Moving Average is calculated to be -50.39%.
Shares Statistics:
Over the past 3-months, GTBP traded about 2.53M shares per day on average, while over the past 10 days, GTBP traded about 2571770 shares per day. A total of 10.64M shares are outstanding, with a floating share count of 9.26M. Insiders hold about 12.92% of the company’s shares, while institutions hold 4.93% stake in the company. Shares short for GTBP as of 1765756800 were 1453242 with a Short Ratio of 0.57, compared to 1763078400 on 1427430. Therefore, it implies a Short% of Shares Outstanding of 1453242 and a Short% of Float of 13.719999999999999.
Earnings Estimates
. The current assessment of GT Biopharma Inc (GTBP) involves the perspectives of 1.0 analysts closely monitoring its market dynamics. Analysts are recommending an EPS of between -$1.66 and -$1.66 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$0.7, with 1.0 analysts recommending between -$0.7 and -$0.7.
